Abrar H.,Naqvi S.,Ahmed M.R.,Ali A.B.,Yasin A.B. .2019 .Ameliorating efect of a betablocker, propranolol on carbamazepine-induced hepatotoxicity in rabbits. Pakistan J. Zool., 51 : 341-346.
Albus U. .2012 .Guide for the care and use of laboratory animals (8th edn). Sage Publications Sage UK, : .
Altuntas Y.,Ozturk B.,Erdem L.,Gunes G.,Karul S.,Ucak S.,Sengul A. .2003 .Phenytoininduced toxic cholestatic hepatitis in a patient with skin lesions: Case report. , 0000051269 : 201-204.
Alturkistani H.A.,Tashkandi F.M.,Mohammedsaleh Z.M. .2016 .Histological stains: A literature review and case study. Glob. J. Hlth. Sci., 8 : 72.
Bhadoria P.,Nagar M.,Bahrioke V.,Bhadoria A.S. .2015 .Efect of ethephon on the liver in albino rats: A histomorphometric study. Biomed. J., 38 : 155589-4170.
Björnsson E. .2008 .Hepatotoxicity associated with antiepileptic drugs. Acta Neurol, 01009 : 0404-290.
Bosia J.,Borzi S.,Cocozzella D.,Corallini O.,Mayet M.,Malca M.,Padrone M.,Rivero A.,Cecchi G.,Fraquelli E. .1999 .Acute liver failure by diphenylhydantoin. Acta gastroenterol. Latinoam., 30 : 73-76.
Cadman B.,Featherstone B. .2003 .Adverse efects of drugs on the liver. Churchill Livingstone, : 843-852.
Curry B.,Mican L.,Smith T.L. .2018 .Phenytoininduced chronic liver enzyme elevation and hepatic ifbrosis: A case report. Mental Hlth. Clin., 07 : 184-187.
D'amico M.,Mejías M.,García-Pras E.,Abraldes J.G.,Garcia-Pagan J.C.,Fernández M.,Bosch J. .2012 .Efects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats. Am. J. Physiol. Gastrointest. Liver Physiol, 302 : G1191-G1198.
Dib N.,Oberti F.,Calès P. .2006 .Current management of the complications of portal hypertension: Variceal bleeding and ascites. Can. med, 174 : 1433-1443.
Diwan B.A.,Henneman J.R.,Nims R.W.,Rice J.M. .1993 .Tumor promotion by an anticonvulsant agent, phenytoin, in mouse liver: Correlation with CYP2B induction. Carcinogenesis, 14 : 2227-2231.
Ekaidem I.S.,Akpanabiatu M.I.,Uboh F.E.,Eka O.U. .2007 .Efect of folic acid and vitamin B12 administration on phenytoin induced toxicity in rats. Indian J. clin. Biochem, 22 : 36-40.
Feroz Z.,Khan R.A. .2013 .Hepatoprotective efect of herbal drug on CCl 4 induced liver damage. Pak. J. Pharma. Sci., 26 : 99-103.
Fizanne L.,Régenet N.,Wang J.,Oberti F.,Moal F.,Roux J.,Gallois Y.,Michalak S.,Calès P. .2008 .Hemodynamic efects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension. Hepatol. Int., 2 : 457-464.
García-Estrada J.,Navarro-Ruíz A.,RománMaldonado S.,Bastidas-Ramírez B.,GonzálezHita M.,Navarro-Ruiz I. .1990 .Oral administration of diphenylhydantoin sodium (DFH-Na or phenytoin) predictably afects the liver and kidney of Sprague Dawley rats. Arch. Investig. Med, 21 : 339-347.
Garzón D.L.M.P.,García-Estrada J.,Navarro-Ruíz A.,Román-Maldonado S.,Bastidas-Ramírez B.,González-Hita M.,Navarro-Ruiz I. .1989 .Oral administration of diphenylhydantoin sodium (DFH-Na or phenytoin) predictably afects the liver and kidney of Sprague Dawley rats. Arch. Invest. Med, 21 : 339-347.
Gazzard B.,Hughes R.,Portmann B.,Dordoni B.,Williams R. .1974 .Protection of rats against the hepatotoxic efect of paracetamol. Br. J. exp. Pathol, 55 : 601.
Huang Q.,Jin X.,Gaillard E.T.,Knight B.L.,Pack F.D.,Stoltz J.H.,Jayadev S.,Blanchard S. .2003 .Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. Mutat. Res. Fundam. Mol. Mech, 12 : 147-167.
Huang Y-Y.,Chung T-W.,Tzeng T-W. .1997 .Drug release from PLA/PEG microparticulates. Int. J. Pharma., 5173(97) : 00154-3.
Hussein R.R.,Soliman R.H.,Ali A.M.A.,Tawfeik M.H.,Abdelrahim M.E. .2013 .Efect of antiepileptic drugs on liver enzymes. Beni-Suef Univ. J. Basic appl. Sci., 09 : 14-19.
Imosemi I.,Osinubi A.,Saalu L.,Olagunju J.A. .2010 .Phenytoin-induced toxicity in the postnatal cerebellar development in rat: Efect of calotropis procera on selective biochemical and haematological variables. Int. J. biol. chem. Sci., 4 : 64974-2396.
Kamp H.,Fabian E.,Groeters S.,Herold M.,Krennrich G.,Looser R.,Mattes W.,Mellert W.,Prokoudine A.,Ruiz-Noppinger P. .2012 .Application of in vivo metabolomics to preclinical/ toxicological studies: Case study on phenytoininduced systemic toxicity. Bioanalysis, 4 : 2291-2301.
Kaplowitz N. .2004 .Drug-induced liver injury. Clin. Infect. Dis., 38 : S44-S48.
Koshy A. .2006 .Medical treatment of portal biliopathy. J. clin. Gastroenterol, 40 : 00004836-454.
Mahendra A.,Hendra P. .2011 .Efek hepatoprotektif infusa daun Macaranga tanarius L. pada tikus jantan terinduksi parasetamol. J. Farmasi Sains dan Komunitas, 8 : 91-99.
Misra H.,Singh S.,Shukla B.,Rai Y.K. .2013 .A study of efect of phenytoin on liver enzymes in epileptic patients in western Uttar Pradesh. -1032.1.2.026, 1 : 11.
Murtey M.D.,Ramasamy P. .2016 .Modern electron microscopy in physical and life sciences. Intech Open, : .
Owoeye O.,Adedara I.A.,Adeyemo O.A.,Bakare O.S.,Egun C.,Farombi E.O. .2014 .Modulatory role of kolaviron in phenytoin-induced hepatic and testicular dysfunctions in Wistar rats. J. Diet. Suppl., 12 : 105-117.
Parasuraman S.,Raveendran R.,Kesavan R. .2010 .Blood sample collection in small laboratory animals. J. Pharmacol. Pharmacother., 1 : 72350-500X.
Patocka J.,Wu Q.,Nepovimova E.,Kuca K. .2020 .Phenytoin-An anti-seizure drug: Overview of its chemistry, pharmacology and toxicology. Fd. Chem, : 111393.
Pizcueta M.P.,De Lacy A.M.,Kravetz D.,Bosch J.,Rodés J. .1989 .Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats. Hepatology, 10 : 953-957.
Poddar U.,Shava U.,Yachha S.K.,Agarwal J.,Kumar S.,Baijal S.S.,Srivastava A. .2015 .β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children. Hepatol. Int., 9 : 447-453.
Rasheed S.,Amanullah A.,Rehman M.H.U.,Javed M. .2012 .Architectural changes of liver in response to alcohol. Gomal J. med. Sci., 9 : 204-207.
Santos N.,Medina W.,Martins N.,Rodrigues M.C.,Curti C.,Santos A. .2008 .Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs. Toxicol, 08 : 1820-1824.
Saraswathy G.,Maheswari E.,Santhrani T. .2010 .Efect of vitamin C supplementation on phenytoin induced hepatotoxicity. Glob. J. Pharmacol., 4 : 127-135.
Saraswathy G.,Maheswari E.,Santhrani T. .2015 .Protective efect of alpha lipoic acid against phenytoin induced behavioral abnormalities in rats. J. Mol. Biomark, : 1000241-9929.
Sasaki E.,Matsuo K.,Iida A.,Tsuneyama K.,Fukami T.,Nakajima M.,Yokoi T. .2013 .A novel mouse model for phenytoin-induced liver injury: Involvement of immune-related factors and P450- mediated metabolism. Toxicol. Sci., 136 : 250-263.
Schmidt D.,Schachter S.C. .2014 .Drug treatment of epilepsy in adults. Br. med. , 348 : .
Sen S.,Ratnaraj N.,Davies N.A.,Mookerjee R.P.,Cooper C.E.,Patsalos P.N.,Williams R.,Jalan R. .2003 .Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia, 31402 : 1157-267.
Sharma V.,Janmeda P. .2013 .Chemopreventive role of Euphorbia neriifolia (Linn) and its isolated lfavonoid against N-nitrosodiethylamine-induced renal histopathological damage in male mice. Toxicol. Int., 20 : 111554-6580.
Singh M.,Shah G.,Singh K. .2000 .Teratogenic efects of dilantin on thoraco-abdominal organs of developing chick embryos. Indian J. exp. Biol, 38 : 1026-1030.
Smythe M.,Umstead G. .1989 .Phenytoin hepatotoxicity: A review of the literature. DICP Annls Pharmacother., 23 : 13-18.
Tursi T. .2010 .Use of ss-blocker therapy to prevent primary bleeding of esophageal varices. J. Am. Acad. Nurse Pract, 00567 : 7599-647.
Vidaurre J.,Gedela S.,Yarosz S. .2017 .Antiepileptic drugs and liver disease. Pediatr. Neurol., 09 : 23-36.
Yoon E.,Babar A.,Choudhary M.,Kutner M.,Pyrsopoulos N. .2015 .Acetaminophen-induced hepatotoxicity: A comprehensive update. J. clin. Transl, 4 : 131.